Ophthalmology News

Science Corporation reported positive preliminary results of a clinical trial examining its Prima retinal implant in patients with central visual field loss due to geographic atrophy.

A number of studies have shown that, among patients undergoing cataract surgery, 80% would seriously consider a refractive implant if they fully understood what it offers.

Ocuphire Pharma has acquired Opus Genetics in an all-stock transaction, with the aim of expanding its position in the gene therapy space for the treatment of inherited retinal diseases, according to a press release.

When we talk about refractive cataract surgery, we are generally talking about giving the patient postoperative vision that provides an enhancement from the standard monofocal IOL with greater spectacle freedom.

Cataract surgery remains one of the most common surgeries performed today, with millions of patients treated every year.

This issue’s cover story on refractive cataract surgery is timely.

Examining the retina, particularly the macula, before cataract surgery is important to set appropriate patient expectations and aid in IOL selection.

The only thing more satisfying than hearing from someone who is thrilled with the results of a recent cataract surgery is learning that the patient experienced no pain during the procedure.

A 92-year-old Asian man was seen in the uveitis ophthalmology clinic due to 2 weeks of bilateral eye injection, pain, tearing and photosensitivity. He denied flashes, floaters, diplopia or metamorphopsia.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.